Tandem Diabetes Care (TNDM) Gains from Investment Securities (2013 - 2022)
Tandem Diabetes Care's (TNDM) quarterly Gains from Investment Securities came in at -$44000.0 in Q4 2022, down 237.5% on a YoY basis from $32000.0 in Q4 2021, and down 266.67% quarter-over-quarter from -$12000.0 in Q3 2022.
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Gains from Investment Securities (2013 - 2022) Analysis & Trends
Tandem Diabetes Care (TNDM) has reported Gains from Investment Securities for 6 consecutive years, with -$44000.0 the latest figure, recorded in Q4 2022.
- For the quarter ending Q4 2022, Gains from Investment Securities fell 237.5% year-over-year to -$44000.0; the trailing twelve-month figure through Dec 2022 stood at -$147000.0 (down 110.61% YoY), and the FY2022 full-year result was -$147000.0, down 110.61% from the prior year.
- Gains from Investment Securities slipped to -$44000.0 in Q4 2022 per TNDM's latest filing, from -$12000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $42.5 million in Q2 2018 and bottomed at -$2.8 million in Q4 2020.
- Historically, Gains from Investment Securities has averaged $4.8 million across 5 years, with a median of $332000.0 in 2021.
- The widest YoY moves for Gains from Investment Securities: up 3281.13% in 2020, down 1347.35% in 2020.
- Over 5 years, Gains from Investment Securities stood at -$2.5 million in 2018, then soared by 108.87% to $226000.0 in 2019, then sank by 1347.35% to -$2.8 million in 2020, then surged by 101.14% to $32000.0 in 2021, then slumped by 237.5% to -$44000.0 in 2022.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered -$44000.0, -$12000.0, and -$57000.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.26 Bn | 808.29 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -44,000.00 |
| Sep 30, 2022 | -12,000.00 |
| Jun 30, 2022 | -57,000.00 |
| Mar 31, 2022 | -34,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 392,000.00 |
| Jun 30, 2021 | 272,000.00 |
| Mar 31, 2021 | 690,000.00 |
| Dec 31, 2020 | -2.82 Mn |
| Sep 30, 2020 | 3.65 Mn |
| Jun 30, 2020 | 14.34 Mn |
| Mar 31, 2020 | 1.92 Mn |
| Dec 31, 2019 | 226,000.00 |
| Sep 30, 2019 | -2.32 Mn |
| Jun 30, 2019 | 424,000.00 |
| Mar 31, 2019 | 12.75 Mn |
| Dec 31, 2018 | -2.55 Mn |
| Sep 30, 2018 | 12.27 Mn |
| Jun 30, 2018 | 42.55 Mn |
| Mar 31, 2018 | 14.23 Mn |